Drug Utilization Review Board
Meeting Agenda
Thursday, October 8, 2026
7:15 a.m. to 8:30 a.m.
Google Meet joining info
Video call link: meet.google.com/qbv-rjpz-fst
Or dial: (US) +1 314-474-3014 PIN: 334 496 072#
Persons who wish to address the DUR Board may contact Luis Moreno at lmoreno@utah.gov at least one week prior to the meeting. A required conflict of interest form must be submitted by the Thursday before the meeting at 12 pm (Mountain Time). Public comments will be limited to 3 minutes per speaker or organization due to time constraints.
1) Call to order - Sharon Weinstein, MD
a) Welcome
b) Review and Approval of Minutes
c) Housekeeping - Luis Moreno, PharmD
2) Prior Authorization Updates - Luis Moreno, PharmD
3) P&T Committee Update - Ngan Huynh, PharmD
4) Annual Training: Utah Open and Public Meetings Act - Clover Meaders
5) Review Topic
a) Biologics for the Treatment of Rheumatoid Arthritis and Psoriatic Arthritis: Role as First-Line Disease Modifying Therapy - Monet Luloh, PharmD
i) Board Discussion/Questions
ii) Board Action
6) Public Comment
7) Review New Prior Authorization Criteria
a) Olumiant (baricitinib) - Iris Wan, PharmD
i) Board Discussion/Questions
ii) Board Action
b) Simponi, Simponi Aria (golimumab) - Kyu Yun Park, PharmD
i) Board Discussion/Questions
ii) Board Action
c) Bixlenvo (bictegravir and lenacapavir - Ngan Huynh, PharmD
i) Board Discussion/Questions
8) Next Meeting
a) Date: November 12, 2026
b) Topic: review Journavx utilization, and new prior authorization criteria for Baxfendy and Zoryve.
9) Adjourned - Sharon Weinstein, MD
Notice of Special Accommodations (ADA)
In compliance with the Americans with Disabilities Act, individuals needing special accommodations (including auxiliary communicative aids and services) during this meeting should notify Luis Moreno at 801-538-6155.
Notice of Electronic or Telephone Participation
Video call link: meet.google.com/qbv-rjpz-fst
Or dial: (US) +1 314-474-3014 PIN: 334 496 072#